{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Q",
          "alt": "P",
          "position": 126
        },
        "variant_string_id": "PINK1 Q126P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 and Parkin physically interact and functionally cooperate to clear damaged mitochondria via autophagy.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism involving PINK1 and Parkin in mitochondrial clearance."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Co-immunoprecipitation experiments were performed to investigate physical interactions between PINK1 and Parkin.",
          "judgment": "Yes",
          "reasoning": "Co-immunoprecipitation is a widely accepted method to study protein-protein interactions."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: PINK1 WT robustly co-immunoprecipitated with Parkin WT. PD-associated mutations were tested alongside WT.\n\nStep 3c: Variant Controls: Known PD-associated mutations (e.g., K161N, K211N, T240R, R275W, G430D) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant forms were used as controls, and experiments were repeated multiple times.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, enhancing the reliability of the functional evidence."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: Several PD-associated mutations were tested, but no direct OddsPath calculation was provided.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: Multiple pathogenic variants were used, leading to moderate strength."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant PINK1 Q126P shows moderate pathogenicity based on its impact on PINK1-Parkin interaction and mitochondrial clearance."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": 347
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 and Parkin physically interact and functionally cooperate to clear damaged mitochondria via autophagy.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism involving PINK1 and Parkin in mitochondrial clearance."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Co-immunoprecipitation experiments were performed to investigate physical interactions between PINK1 and Parkin.",
          "judgment": "Yes",
          "reasoning": "Co-immunoprecipitation is a widely accepted method to study protein-protein interactions."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: PINK1 WT robustly co-immunoprecipitated with Parkin WT. PD-associated mutations were tested alongside WT.\n\nStep 3c: Variant Controls: Known PD-associated mutations (e.g., K161N, K211N, T240R, R275W, G430D) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant forms were used as controls, and experiments were repeated multiple times.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, enhancing the reliability of the functional evidence."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: Several PD-associated mutations were tested, but no direct OddsPath calculation was provided.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: Multiple pathogenic variants were used, leading to moderate strength."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant PINK1 L347P shows moderate pathogenicity based on its impact on PINK1-Parkin interaction and mitochondrial clearance."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": 437
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 and Parkin physically interact and functionally cooperate to clear damaged mitochondria via autophagy.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism involving PINK1 and Parkin in mitochondrial clearance."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Co-immunoprecipitation experiments were performed to investigate physical interactions between PINK1 and Parkin.",
          "judgment": "Yes",
          "reasoning": "Co-immunoprecipitation is a widely accepted method to study protein-protein interactions."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: PINK1 WT robustly co-immunoprecipitated with Parkin WT. PD-associated mutations were tested alongside WT.\n\nStep 3c: Variant Controls: Known PD-associated mutations (e.g., K161N, K211N, T240R, R275W, G430D) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both wild-type and mutant forms were used as controls, and experiments were repeated multiple times.\n\nStep 3c: Variant Controls: Known pathogenic variants were used as controls, enhancing the reliability of the functional evidence."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: Several PD-associated mutations were tested, but no direct OddsPath calculation was provided.",
          "judgment": "Partial",
          "reasoning": "Step 4b: No OddsPath Calculation: Multiple pathogenic variants were used, leading to moderate strength."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The variant PINK1 W437X shows moderate pathogenicity based on its impact on PINK1-Parkin interaction and mitochondrial clearance."
    }
  ]
}